V. Charles Charuvastra

1.0k total citations
23 papers, 830 citations indexed

About

V. Charles Charuvastra is a scholar working on Public Health, Environmental and Occupational Health, Toxicology and Epidemiology. According to data from OpenAlex, V. Charles Charuvastra has authored 23 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 8 papers in Toxicology and 6 papers in Epidemiology. Recurrent topics in V. Charles Charuvastra's work include Opioid Use Disorder Treatment (11 papers), Forensic Toxicology and Drug Analysis (8 papers) and Substance Abuse Treatment and Outcomes (5 papers). V. Charles Charuvastra is often cited by papers focused on Opioid Use Disorder Treatment (11 papers), Forensic Toxicology and Drug Analysis (8 papers) and Substance Abuse Treatment and Outcomes (5 papers). V. Charles Charuvastra collaborates with scholars based in United States. V. Charles Charuvastra's co-authors include Walter Ling, Peggy Compton, Murray E. Jarvik, Ya-Ching Hsieh, Xiaowei Yang, Erin Rotheram‐Fuller, Steven Shoptaw, Jim Mintz, Jed E. Rose and Gayle M. Boyd and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Psychiatry and Drug and Alcohol Dependence.

In The Last Decade

V. Charles Charuvastra

22 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Charles Charuvastra United States 9 325 276 241 207 144 23 830
Dorothy Melia United States 6 273 0.8× 401 1.5× 179 0.7× 319 1.5× 203 1.4× 7 1.0k
Jeanne M. Manubay United States 21 184 0.6× 275 1.0× 360 1.5× 179 0.9× 118 0.8× 32 852
G. E. Bigelow United States 8 100 0.3× 175 0.6× 245 1.0× 66 0.3× 110 0.8× 22 543
Anne Geller United States 15 153 0.5× 152 0.6× 301 1.2× 260 1.3× 33 0.2× 26 877
Thomas Kosten United States 17 94 0.3× 325 1.2× 367 1.5× 77 0.4× 134 0.9× 29 1.1k
M J Kreek United States 14 148 0.5× 499 1.8× 150 0.6× 48 0.2× 276 1.9× 26 943
T. Peter Bridge United States 16 74 0.2× 211 0.8× 440 1.8× 94 0.5× 80 0.6× 32 1.1k
George E. Bigelow United States 14 200 0.6× 434 1.6× 932 3.9× 199 1.0× 330 2.3× 16 1.6k
J H Mendelson United States 24 176 0.5× 808 2.9× 274 1.1× 47 0.2× 435 3.0× 36 1.7k
MarkS. Gold United States 6 104 0.3× 323 1.2× 79 0.3× 58 0.3× 212 1.5× 7 604

Countries citing papers authored by V. Charles Charuvastra

Since Specialization
Citations

This map shows the geographic impact of V. Charles Charuvastra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Charles Charuvastra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Charles Charuvastra more than expected).

Fields of papers citing papers by V. Charles Charuvastra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Charles Charuvastra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Charles Charuvastra. The network helps show where V. Charles Charuvastra may publish in the future.

Co-authorship network of co-authors of V. Charles Charuvastra

This figure shows the co-authorship network connecting the top 25 collaborators of V. Charles Charuvastra. A scholar is included among the top collaborators of V. Charles Charuvastra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Charles Charuvastra. V. Charles Charuvastra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Compton, Peggy, V. Charles Charuvastra, & Walter Ling. (2003). Effect of oral ketorolac and gender on human cold pressor pain tolerance. Clinical and Experimental Pharmacology and Physiology. 30(10). 759–763. 28 indexed citations
2.
Shoptaw, Steven, Xiaowei Yang, Erin Rotheram‐Fuller, et al.. (2003). Randomized Placebo-Controlled Trial of Baclofen for Cocaine Dependence. The Journal of Clinical Psychiatry. 64(12). 1440–1448. 170 indexed citations
3.
Compton, Peggy, V. Charles Charuvastra, & Walter Ling. (2001). Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug and Alcohol Dependence. 63(2). 139–146. 245 indexed citations
4.
Compton, Peggy, et al.. (2000). Pain Responses in Methadone-Maintained Opioid Abusers. Journal of Pain and Symptom Management. 20(4). 237–245. 135 indexed citations
5.
Compton, Peggy, Donald R. Wesson, V. Charles Charuvastra, & Walter Ling. (1996). Buprenorphine as a Pharmacotherapy for Opiate Addiction: What Dose Provides a Therapeutic Response?. American Journal on Addictions. 5(3). 220–230. 13 indexed citations
6.
Compton, Peggy, et al.. (1996). Urine Toxicology as an Outcome Measure in Drug Abuse Clinical Trials:. Journal of Addictive Diseases. 15(2). 85–92. 7 indexed citations
7.
Compton, Peggy, Donald R. Wesson, V. Charles Charuvastra, & Walter Ling. (1996). Buprenorphine as a Pharmacotherapy for Opiate Addiction What Dose Provides a Therapeutic Response?. American Journal on Addictions. 5(3). 220–230. 2 indexed citations
8.
Compton, Peggy, et al.. (1995). Buprenorphine as a Pharmacotherapy for Cocaine Abuse:. Journal of Addictive Diseases. 14(3). 97–114. 19 indexed citations
9.
Charuvastra, V. Charles, et al.. (1991). Outcome Study: Comparison of Short-Term vs Long-Term Treatment in a Residential Community. International Journal of the Addictions. 27(1). 15–23. 5 indexed citations
10.
Charuvastra, V. Charles, et al.. (1989). Drug-free therapeutic community: A ten-year follow-up. Addictive Behaviors. 14(3). 343–345. 2 indexed citations
11.
Charuvastra, V. Charles. (1981). Drug Free Therapeutic Community — A Five-Year Follow UP. Journal of Drug Education. 11(3). 275–280. 8 indexed citations
12.
Charuvastra, V. Charles. (1980). Follow-up study of subjects on methadyl acetate and methadone. Drug and Alcohol Dependence. 6(5). 273–284. 2 indexed citations
13.
Sideroff, Stephen I., et al.. (1978). Craving in Heroin Addicts Maintained on the Opiate Antagonist Naltrexone. The American Journal of Drug and Alcohol Abuse. 5(4). 415–423. 35 indexed citations
14.
Charuvastra, V. Charles, et al.. (1977). METHADYL ACETATE VERSUS METHADONE: THE EXPERIENCE OF ONE HOSPITAL. The Medical Journal of Australia. 2(5). 150–152. 8 indexed citations
15.
Charuvastra, V. Charles, et al.. (1977). RENAL FAILURE AND TREATMENT OF A METHADONE MAINTENANCE PATIENT. The Medical Journal of Australia. 2(13). 433–434. 6 indexed citations
16.
Charuvastra, V. Charles, et al.. (1977). Renal Failure and Heroin Addiction: A Management Paradigm. Journal of Drug Education. 7(4). 353–357. 1 indexed citations
17.
Gritz, Ellen R., Saul Shiffman, Murray E. Jarvik, Joseph J. Schlesinger, & V. Charles Charuvastra. (1976). Naltrexone: Physiological and psychological effects of single doses. Clinical Pharmacology & Therapeutics. 19(6). 773–776. 34 indexed citations
18.
Charuvastra, V. Charles, et al.. (1976). Training of Paraprofessionals—Some Caveats. Journal of Drug Education. 6(2). 105–112. 3 indexed citations
19.
Charuvastra, V. Charles, et al.. (1975). Incidence of Hepatitis-Associated Antigen among Male Narcotic Addicts in a Drug Treatment Program. International Journal of the Addictions. 10(6). 1055–1059. 1 indexed citations
20.
Charuvastra, V. Charles, et al.. (1974). Eosinophilia in veteran heroin addicts.. PubMed. 32(3). 134–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dorothy Melia Breakdown of academic impact, for papers by Jeanne M. Manubay Breakdown of academic impact, for papers by G. E. Bigelow Breakdown of academic impact, for papers by Anne Geller Breakdown of academic impact, for papers by Thomas Kosten Breakdown of academic impact, for papers by M J Kreek Breakdown of academic impact, for papers by T. Peter Bridge Breakdown of academic impact, for papers by George E. Bigelow Breakdown of academic impact, for papers by J H Mendelson Breakdown of academic impact, for papers by MarkS. Gold
Rankless by CCL
2026